Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Iqrar Ahmad

Showing results (1-10 of 155) with videos related to

Pageof 16
Sort By:
Journal of Biochemical and Molecular Toxicology|December 24, 2024
Design, Synthesis, and Evaluation of Novel 2,4-disubstituted Pyrimidine Derivatives as Double Mutant Epidermal Growth Factor Receptor-L858R/T790M Tyrosine Kinase InhibitorsIqrar Ahmad, Harun Patel
Drug Development Research|December 26, 2024
Orthoallosteric EGFR-TKIs: A New Paradigm in NSCLC Treatment Strategy Targeting the C797S MutationIqrar Ahmad, Harun M Patel
Journal of Cellular Biochemistry|September 20, 2024
Repurposing Non-Nucleosidic Reverse Transcriptase Inhibitors (NNRTIs) to Overcome EGFR T790M-Mediated Acquired Resistance in Non-Small Cell Lung CancerIqrar Ahmad, Harun M Patel
European Journal of Medicinal Chemistry|December 26, 2024
From challenges to solutions: A review of fourth-generation EGFR tyrosine kinase inhibitors to overcome the C797S triple mutation in non-small cell lung cancerIqrar Ahmad, Harun M Patel
Journal of Biomolecular Structure & Dynamics|April 25, 2023
Bioisosteric modification of Linezolid identified the potential <i>M. tuberculosis</i> protein synthesis inhibitors to overcome the myelosuppression and serotonergic toxicity associated with Linezolid in the treatment of the multi-drug resistance tuberculosis (MDR-TB)Rukaiyya Girase, Iqrar Ahmad, Harun Patel
Journal of Biomolecular Structure & Dynamics|May 10, 2021
Computational investigation of phytochemicals from <i>Withania somnifera</i> (Indian ginseng/ashwagandha) as plausible inhibitors of GluN2B-containing NMDA receptorsIqrar Ahmad, Dileep Kumar, Harun Patel
Springerplus|August 19, 2016
Socio-economic characterisation of date palm (Phoenix dactylifera L.) growers and date value chains in PakistanGhayoor Fatima, Iqrar Ahmad Khan, Andreas Buerkert
European Journal of Medicinal Chemistry|June 12, 2021
The Mur Enzymes Chink in the Armour of Mycobacterium tuberculosis cell wallYashodeep Shinde, Iqrar Ahmad, Sanjay Surana, et al.
In Silico Pharmacology|October 11, 2021
Computational identification of 2,4-disubstituted amino-pyrimidines as L858R/T790M-EGFR double mutant inhibitors using pharmacophore mapping, molecular docking, binding free energy calculation, DFT study and molecular dynamic simulationRahul Pawara, Iqrar Ahmad, Sanjay Surana, et al.
Topics in Current Chemistry (Cham)|October 8, 2021
The Repurposed ACE2 Inhibitors: SARS-CoV-2 Entry Blockers of Covid-19Iqrar Ahmad, Rahul Pawara, Sanjay Surana, et al.
Pageof 16

Showing results (1-10 of 155) with videos related to

Sort By:
Pageof 16
Journal of Biochemical and Molecular Toxicology|December 24, 2024
Design, Synthesis, and Evaluation of Novel 2,4-disubstituted Pyrimidine Derivatives as Double Mutant Epidermal Growth Factor Receptor-L858R/T790M Tyrosine Kinase InhibitorsIqrar Ahmad, Harun Patel
Drug Development Research|December 26, 2024
Orthoallosteric EGFR-TKIs: A New Paradigm in NSCLC Treatment Strategy Targeting the C797S MutationIqrar Ahmad, Harun M Patel
Journal of Cellular Biochemistry|September 20, 2024
Repurposing Non-Nucleosidic Reverse Transcriptase Inhibitors (NNRTIs) to Overcome EGFR T790M-Mediated Acquired Resistance in Non-Small Cell Lung CancerIqrar Ahmad, Harun M Patel
European Journal of Medicinal Chemistry|December 26, 2024
From challenges to solutions: A review of fourth-generation EGFR tyrosine kinase inhibitors to overcome the C797S triple mutation in non-small cell lung cancerIqrar Ahmad, Harun M Patel
Journal of Biomolecular Structure & Dynamics|April 25, 2023
Bioisosteric modification of Linezolid identified the potential <i>M. tuberculosis</i> protein synthesis inhibitors to overcome the myelosuppression and serotonergic toxicity associated with Linezolid in the treatment of the multi-drug resistance tuberculosis (MDR-TB)Rukaiyya Girase, Iqrar Ahmad, Harun Patel
Journal of Biomolecular Structure & Dynamics|May 10, 2021
Computational investigation of phytochemicals from <i>Withania somnifera</i> (Indian ginseng/ashwagandha) as plausible inhibitors of GluN2B-containing NMDA receptorsIqrar Ahmad, Dileep Kumar, Harun Patel
Springerplus|August 19, 2016
Socio-economic characterisation of date palm (Phoenix dactylifera L.) growers and date value chains in PakistanGhayoor Fatima, Iqrar Ahmad Khan, Andreas Buerkert
European Journal of Medicinal Chemistry|June 12, 2021
The Mur Enzymes Chink in the Armour of Mycobacterium tuberculosis cell wallYashodeep Shinde, Iqrar Ahmad, Sanjay Surana, et al.
In Silico Pharmacology|October 11, 2021
Computational identification of 2,4-disubstituted amino-pyrimidines as L858R/T790M-EGFR double mutant inhibitors using pharmacophore mapping, molecular docking, binding free energy calculation, DFT study and molecular dynamic simulationRahul Pawara, Iqrar Ahmad, Sanjay Surana, et al.
Topics in Current Chemistry (Cham)|October 8, 2021
The Repurposed ACE2 Inhibitors: SARS-CoV-2 Entry Blockers of Covid-19Iqrar Ahmad, Rahul Pawara, Sanjay Surana, et al.
Pageof 16